Progenics’ monoclonal antibodies constitute a non-antibiotic treatment strategy that is designed to block the harmful effects of the disease-causing toxins produced by C difficile. Progenics Pharma founder, CEO
Aridol is a single-use, indirect test that is easy-to-administer, requires minimal preparation time and only a 15% reduction in lung function from baseline, Pharmaxis said. Aridol is used
Lysteda Phase 3 trial is a double-blind, placebo-controlled 6-month study which assessed the drug in women ages 18-49 years with HMB, defined as mean menstrual blood loss of
The patent claims are directed to formulations of Vinorelbine Bitartrate and provide protection for the company’s lead product candidate, ANX-530 (Vinorelbine injectable emulsion), or Exelbine. The notice of
Verisens PSA is an in-vitro diagnostic assay for the high-sensitivity detection and quantification of prostate specific antigen (PSA), developed in collaboration with the International Institute for Nanotechnology at
The patent entitled ‘Methods for Treatment with Bucindolol Based on Genetic Targeting,’ provides protection for this approach to treat patients with heart failure in France, Germany, Netherlands, Switzerland/Liechtenstein,
BioClinica has said that its client has choosen BioClinica Express as part of a broad evaluation of all the solutions to achieve its goal of running paperless clinic
Clariant claims that the new Mevopur brand acknowledges the pharmaceutical and medical industry’s need for material consistency, reliability and change-control and can help brand owners and manufacturers minimise
Following the acquisition, both the companies are expected to combine their expertise in medication analytics to enhance diversion detection and clinical benchmarking that helps to ensure regulatory compliance.
Watson’s Rasagiline mesylate tablets are generic versions of Teva Neuroscience’s Azilect tablets, which are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease as
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.